Logo image of PODD

INSULET CORP (PODD) Stock Fundamental Analysis

USA - NASDAQ:PODD - US45784P1012 - Common Stock

318 USD
-5.58 (-1.72%)
Last: 9/26/2025, 8:23:43 PM
318 USD
0 (0%)
After Hours: 9/26/2025, 8:23:43 PM
Fundamental Rating

7

Overall PODD gets a fundamental rating of 7 out of 10. We evaluated PODD against 191 industry peers in the Health Care Equipment & Supplies industry. While PODD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. PODD is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, PODD could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year PODD was profitable.
PODD had a positive operating cash flow in the past year.
PODD had positive earnings in each of the past 5 years.
Of the past 5 years PODD 4 years had a positive operating cash flow.
PODD Yearly Net Income VS EBIT VS OCF VS FCFPODD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

The Return On Assets of PODD (6.81%) is better than 87.43% of its industry peers.
With an excellent Return On Equity value of 16.14%, PODD belongs to the best of the industry, outperforming 91.10% of the companies in the same industry.
PODD has a Return On Invested Capital of 13.08%. This is amongst the best in the industry. PODD outperforms 92.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PODD is below the industry average of 8.43%.
The 3 year average ROIC (6.40%) for PODD is below the current ROIC(13.08%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.81%
ROE 16.14%
ROIC 13.08%
ROA(3y)7.24%
ROA(5y)4.58%
ROE(3y)21.22%
ROE(5y)13.56%
ROIC(3y)6.4%
ROIC(5y)5.42%
PODD Yearly ROA, ROE, ROICPODD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

PODD has a better Profit Margin (10.01%) than 82.20% of its industry peers.
PODD's Profit Margin has improved in the last couple of years.
The Operating Margin of PODD (17.26%) is better than 87.96% of its industry peers.
In the last couple of years the Operating Margin of PODD has grown nicely.
Looking at the Gross Margin, with a value of 70.74%, PODD belongs to the top of the industry, outperforming 81.15% of the companies in the same industry.
PODD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.26%
PM (TTM) 10.01%
GM 70.74%
OM growth 3Y9.15%
OM growth 5Y17.1%
PM growth 3Y136.37%
PM growth 5Y66.64%
GM growth 3Y0.65%
GM growth 5Y1.41%
PODD Yearly Profit, Operating, Gross MarginsPODD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PODD is still creating some value.
The number of shares outstanding for PODD has been increased compared to 1 year ago.
Compared to 5 years ago, PODD has more shares outstanding
Compared to 1 year ago, PODD has an improved debt to assets ratio.
PODD Yearly Shares OutstandingPODD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PODD Yearly Total Debt VS Total AssetsPODD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

PODD has an Altman-Z score of 8.24. This indicates that PODD is financially healthy and has little risk of bankruptcy at the moment.
PODD's Altman-Z score of 8.24 is amongst the best of the industry. PODD outperforms 89.53% of its industry peers.
The Debt to FCF ratio of PODD is 3.66, which is a good value as it means it would take PODD, 3.66 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 3.66, PODD belongs to the best of the industry, outperforming 84.82% of the companies in the same industry.
PODD has a Debt/Equity ratio of 0.64. This is a neutral value indicating PODD is somewhat dependend on debt financing.
PODD's Debt to Equity ratio of 0.64 is on the low side compared to the rest of the industry. PODD is outperformed by 69.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 3.66
Altman-Z 8.24
ROIC/WACC1.54
WACC8.47%
PODD Yearly LT Debt VS Equity VS FCFPODD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

PODD has a Current Ratio of 2.26. This indicates that PODD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.26, PODD is in line with its industry, outperforming 43.46% of the companies in the same industry.
A Quick Ratio of 1.81 indicates that PODD should not have too much problems paying its short term obligations.
The Quick ratio of PODD (1.81) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 1.81
PODD Yearly Current Assets VS Current LiabilitesPODD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

9

3. Growth

3.1 Past

PODD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.78%, which is quite impressive.
PODD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 79.24% yearly.
The Revenue has grown by 25.99% in the past year. This is a very strong growth!
PODD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.92% yearly.
EPS 1Y (TTM)24.78%
EPS 3Y58.9%
EPS 5Y79.24%
EPS Q2Q%112.73%
Revenue 1Y (TTM)25.99%
Revenue growth 3Y23.54%
Revenue growth 5Y22.92%
Sales Q2Q%32.88%

3.2 Future

PODD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.27% yearly.
The Revenue is expected to grow by 17.30% on average over the next years. This is quite good.
EPS Next Y42.27%
EPS Next 2Y33%
EPS Next 3Y30.26%
EPS Next 5Y24.27%
Revenue Next Year27.56%
Revenue Next 2Y22.76%
Revenue Next 3Y20.85%
Revenue Next 5Y17.3%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PODD Yearly Revenue VS EstimatesPODD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
PODD Yearly EPS VS EstimatesPODD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 75.18, the valuation of PODD can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of PODD indicates a somewhat cheap valuation: PODD is cheaper than 64.92% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.32. PODD is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 53.98, which means the current valuation is very expensive for PODD.
67.54% of the companies in the same industry are more expensive than PODD, based on the Price/Forward Earnings ratio.
PODD is valuated expensively when we compare the Price/Forward Earnings ratio to 22.89, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 75.18
Fwd PE 53.98
PODD Price Earnings VS Forward Price EarningsPODD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

67.02% of the companies in the same industry are more expensive than PODD, based on the Enterprise Value to EBITDA ratio.
PODD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PODD is cheaper than 74.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 58.54
EV/EBITDA 46.13
PODD Per share dataPODD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PODD has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as PODD's earnings are expected to grow with 30.26% in the coming years.
PEG (NY)1.78
PEG (5Y)0.95
EPS Next 2Y33%
EPS Next 3Y30.26%

0

5. Dividend

5.1 Amount

No dividends for PODD!.
Industry RankSector Rank
Dividend Yield N/A

INSULET CORP

NASDAQ:PODD (9/26/2025, 8:23:43 PM)

After market: 318 0 (0%)

318

-5.58 (-1.72%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/amc
Inst Owners101.85%
Inst Owner Change-3.42%
Ins Owners0.27%
Ins Owner Change0.11%
Market Cap22.38B
Analysts85
Price Target363.71 (14.37%)
Short Float %2.31%
Short Ratio2.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.1%
Min EPS beat(2)23.7%
Max EPS beat(2)24.5%
EPS beat(4)4
Avg EPS beat(4)18.52%
Min EPS beat(4)10.04%
Max EPS beat(4)24.5%
EPS beat(8)7
Avg EPS beat(8)42.02%
EPS beat(12)11
Avg EPS beat(12)52.31%
EPS beat(16)13
Avg EPS beat(16)23.76%
Revenue beat(2)2
Avg Revenue beat(2)3.3%
Min Revenue beat(2)2.66%
Max Revenue beat(2)3.94%
Revenue beat(4)4
Avg Revenue beat(4)2.46%
Min Revenue beat(4)0.51%
Max Revenue beat(4)3.94%
Revenue beat(8)8
Avg Revenue beat(8)3.27%
Revenue beat(12)12
Avg Revenue beat(12)4.16%
Revenue beat(16)15
Avg Revenue beat(16)3.15%
PT rev (1m)1.25%
PT rev (3m)5.47%
EPS NQ rev (1m)0.02%
EPS NQ rev (3m)3.89%
EPS NY rev (1m)0.15%
EPS NY rev (3m)7.09%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)4.96%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)3.72%
Valuation
Industry RankSector Rank
PE 75.18
Fwd PE 53.98
P/S 9.49
P/FCF 58.54
P/OCF 44.2
P/B 15.3
P/tB 17.1
EV/EBITDA 46.13
EPS(TTM)4.23
EY1.33%
EPS(NY)5.89
Fwd EY1.85%
FCF(TTM)5.43
FCFY1.71%
OCF(TTM)7.19
OCFY2.26%
SpS33.52
BVpS20.78
TBVpS18.6
PEG (NY)1.78
PEG (5Y)0.95
Profitability
Industry RankSector Rank
ROA 6.81%
ROE 16.14%
ROCE 16.56%
ROIC 13.08%
ROICexc 21.95%
ROICexgc 24.52%
OM 17.26%
PM (TTM) 10.01%
GM 70.74%
FCFM 16.21%
ROA(3y)7.24%
ROA(5y)4.58%
ROE(3y)21.22%
ROE(5y)13.56%
ROIC(3y)6.4%
ROIC(5y)5.42%
ROICexc(3y)9.71%
ROICexc(5y)8.89%
ROICexgc(3y)10.75%
ROICexgc(5y)9.79%
ROCE(3y)8.12%
ROCE(5y)6.87%
ROICexcg growth 3Y16.78%
ROICexcg growth 5Y18.66%
ROICexc growth 3Y15.99%
ROICexc growth 5Y18.5%
OM growth 3Y9.15%
OM growth 5Y17.1%
PM growth 3Y136.37%
PM growth 5Y66.64%
GM growth 3Y0.65%
GM growth 5Y1.41%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 3.66
Debt/EBITDA 1.9
Cap/Depr 142.86%
Cap/Sales 5.26%
Interest Coverage 250
Cash Conversion 102.49%
Profit Quality 161.97%
Current Ratio 2.26
Quick Ratio 1.81
Altman-Z 8.24
F-Score6
WACC8.47%
ROIC/WACC1.54
Cap/Depr(3y)188.25%
Cap/Depr(5y)215.81%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.78%
EPS 3Y58.9%
EPS 5Y79.24%
EPS Q2Q%112.73%
EPS Next Y42.27%
EPS Next 2Y33%
EPS Next 3Y30.26%
EPS Next 5Y24.27%
Revenue 1Y (TTM)25.99%
Revenue growth 3Y23.54%
Revenue growth 5Y22.92%
Sales Q2Q%32.88%
Revenue Next Year27.56%
Revenue Next 2Y22.76%
Revenue Next 3Y20.85%
Revenue Next 5Y17.3%
EBIT growth 1Y49.36%
EBIT growth 3Y34.84%
EBIT growth 5Y43.94%
EBIT Next Year100.35%
EBIT Next 3Y43.79%
EBIT Next 5Y32.74%
FCF growth 1Y1593.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y233.38%
OCF growth 3YN/A
OCF growth 5Y34.32%